Patents Assigned to Healthpoint
-
Patent number: 8453525Abstract: A plasma sample collection device includes an elongated blood separation strip having a constant width and a relatively narrower end portion. A support base is located under the plasma separator strip and a cover is positioned superincumbent with respect to the blood separator strip. The cover defines an elongated observation window extending along the length of the plasma separator strip. An oblong collection port is adjacent to but spaced from one end of the observation window. The oblong collection port exposes the separator strip end portion and has a chief axis substantially aligned with the longitudinal axis of the blood separation strip. In one embodiment, the collection port has a teardrop configuration, and in another embodiment it has an obovate-cuneate configuration.Type: GrantFiled: February 9, 2010Date of Patent: June 4, 2013Assignee: HealthPoint Diagnostix, Inc.Inventor: John P. Kramer
-
Publication number: 20130052168Abstract: A kit is disclosed that includes a first component comprising alginate, wherein the first component is comprised in a first sterile vial, and a second component comprising cells comprising keratinocytes or fibroblasts, or mixtures thereof, that secrete one or more biologically active molecules selected from the group consisting of GM-CSF, VEGF, KGF, bFGF, TGF?, angiopoietin, EGF, IL-I?, IL-6, IL-8, TGF?, and TNF?, wherein the cells are allogeneic and mitotically inactive, a buffered solution, and human serum albumin or a cryoprotectant, wherein the second component is comprised in a second sterile vial.Type: ApplicationFiled: October 24, 2012Publication date: February 28, 2013Applicant: HEALTHPOINT INTERNATIONAL, LLCInventor: Healthpoint International, LLC
-
Publication number: 20130045196Abstract: The present invention is directed to topical enzymatic wound debriding compositions with enhanced enzymatic activity. These compositions comprise a dispersed phase comprising at least one proteolytic enzyme and at least one hydrophilic polyol; and a continuous phase comprising a hydrophobic base.Type: ApplicationFiled: December 8, 2010Publication date: February 21, 2013Applicant: HEALTHPOINT, LTD.Inventors: Lei Shi, Aleksa Jovanovic, Duncan Aust
-
Patent number: 7785584Abstract: A spray-on topical wound debrider spray is prepared forming a mist, spray or foam which will not drip significantly after application. The preferred wound debrider is papain. The spray contains a surfactant emulsifier admixture having a composition viscosity of from about 5000 cps to about 50,000 cps and is preferably a fatty alcohol phosphate ester emulsifier composition.Type: GrantFiled: August 13, 2003Date of Patent: August 31, 2010Assignee: Healthpoint, Ltd.Inventors: David P. Jones, Robert Espinoza
-
Publication number: 20070010586Abstract: The addition of alcohol plus acetate salts unexpectedly enhanced the tuberculocidal activity of glutaraldehyde, and decreased the fumes of glutaraldehyde from the formula of a high-level disinfectant.Type: ApplicationFiled: July 11, 2005Publication date: January 11, 2007Applicant: Healthpoint, Ltd.Inventor: Norman Miner
-
Publication number: 20070003486Abstract: A spray-on topical wound debrider spray is prepared forming a mist, spray or foam which will not drip significantly after application. The preferred wound debrider is papain. The spray contains a surfactant emulsifier admixture having a composition viscosity of from about 5000 cps to about 50,000 cps and is preferably a fatty alcohol phosphate ester emulsifier composition.Type: ApplicationFiled: June 8, 2006Publication date: January 4, 2007Applicant: Healthpoint, Ltd.Inventors: David Jones, Robert Espinoza
-
Patent number: 6910822Abstract: A liquid dispenser applicator for preoperative preparation of a target area of a patient's skin is comprised of two integrated components, a handle portion and a canister vessel. The two components are locked by a locking and sealing ring mechanism to prevent accidental rupture of the sterile antiseptic fluid in the canister vessel. When the lock is unlocked, the unit contains a perforator designed to initially slit the membrane followed by pushing it open further and thereafter venting it to provide dual-staged self-venting by the perforator for ease of flow.Type: GrantFiled: November 14, 2002Date of Patent: June 28, 2005Assignee: Healthpoint, Ltd.Inventors: Rex A. Hidle, Shawn B. Gentry, H. Paul Dorman
-
Publication number: 20040204492Abstract: A topical composition and method for treating seborrehic dermatitis designed specifically to allow for short duration skin contact time. It is a water rinseable sulfacetamide composition free of elemental sulfur, preferably dosed in a regimen of at least two daily treatments.Type: ApplicationFiled: April 3, 2003Publication date: October 14, 2004Applicant: Healthpoint, Ltd.Inventors: Braham Shroot, Robert Espinoza, Jimmy Joe Willis
-
Patent number: 6783767Abstract: A powder composition which reacts in water to form in situ peroxycarboxylic acids at an anti-microbially effective concentration. Importantly, its utility is both for topical anti-microbial application and for effective low temperature disinfection/sterilization of instruments. It comprises the combination of a perborate, one or more novel acyl and/or aroyl donors, a buffering system which allows the pH to arise to about 9 for rapid formation of the peroxycarboxylic acids and then drop to about 7.5 for sustained stability and microbial kill. It preferably includes a surfactant facilitating antimicrobial efficacy, as well as other minors.Type: GrantFiled: February 8, 2002Date of Patent: August 31, 2004Assignee: Healthpoint, Ltd.Inventors: Braham Shroot, Lawton A. Seal, James R. Hunt, Jonathan Sterling, Kathy Bolsen, Penny L. Sitka
-
Publication number: 20040142020Abstract: An anhydrous, hydrophilic wound dressing containing a superabsorbent polymer. Its anhydrous nature allows it, when applied to a wound site, to absorb wound fluid.Type: ApplicationFiled: January 16, 2003Publication date: July 22, 2004Applicant: Healthpoint, Ltd.Inventors: David P. Jones, David W. Hobson, Pilar P. Duque
-
Patent number: 6709663Abstract: A topical delivery composition which employs a multivesicular emulsion in combination with a pharmaceutically/pharmacologically active agent is disclosed. The multivesicular emulsion is formed from a quaternary amine salt emulsifier such as behentrimonium methosulfate. The emulsion is multi-lamellar which is a series of concentric spheres or vesiculars of oil and water phase that can be seen microscopically. As a result, the active is time released over a sustained period rather than spike released as is common with most topicals.Type: GrantFiled: August 31, 2001Date of Patent: March 23, 2004Assignee: HealthPoint, Ltd.Inventor: Robert Espinoza
-
Patent number: 6698616Abstract: The present invention discloses a method, apparatus and system for electromechanical liquid dispensing. The system includes a bottle for holding liquid to be dispensed, the bottle having an inlet port and an outlet port, a one-way outlet valve on the outlet port through which liquid is dispensed from the bottle, and an electronic control system for controlling dispensement of the liquid from the outlet port such that a controlled quantity of liquid is dispensed.Type: GrantFiled: June 10, 2002Date of Patent: March 2, 2004Assignee: HealthPoint, Ltd.Inventors: Rex A. Hidle, Paul H. Dorman, Martin E. Smith, Earl R. Boyer, Stuart Daley, Shawn B. Gentry
-
Publication number: 20030198632Abstract: An enzymatic wound debrider which employs in combination a topical dosage form pharmaceutical carrier and a debridement agent which is thermolysin preferably in combination with an ionic co-factor of either zinc ions, or calcium ions, or both.Type: ApplicationFiled: November 26, 2002Publication date: October 23, 2003Applicant: Healthpoint, Ltd.Inventors: Lei Shi, David P. Jones, Robert Espinoza, Braham Shroot
-
Publication number: 20030198631Abstract: An enzymatic wound debrider which employs in combination a topical dosage form pharmaceutical carrier and a debridement agent which is thermolysin preferably in combination with an ionic co-factor of either zinc ions, or calcium ions, or both.Type: ApplicationFiled: April 18, 2002Publication date: October 23, 2003Applicant: Healthpoint, Ltd.Inventors: Lei Shi, David P. Jones, Robert Espinoza, Braham Shroot
-
Publication number: 20030157192Abstract: A powder composition which reacts in water to form in situ peroxycarboxylic acids at an anti-microbially effective concentration. Importantly, its utility is both for topical anti-microbial application and for effective low temperature disinfection/sterilization of instruments. It comprises the combination of a perborate, one or more novel acyl and/or aroyl donors, a buffering system which allows the pH to arise to about 9 for rapid formation of the peroxycarboxylic acids and then drop to about 7.5 for sustained stability and microbial kill. It preferably includes a surfactant facilitating antimicrobial efficacy, as well as other minors.Type: ApplicationFiled: February 8, 2002Publication date: August 21, 2003Applicant: Healthpoint, Ltd.Inventors: Braham Shroot, Lawton A. Seal, James R. Hunt, Jonathan Sterling, Kathy Bolsen, Penny L. Sitka
-
Patent number: 6548556Abstract: This invention relates to an enzymatic anhydrous hydrophilic wound debrider that uses in combination a proteolytic enzyme and an anhydrous hydrophilic poloxamer carrier.Type: GrantFiled: December 27, 2000Date of Patent: April 15, 2003Assignee: Healthpoint, Ltd.Inventors: David W. Hobson, David P. Jones, Katarzyna Koster, Pilar P. Duque
-
Publication number: 20030068190Abstract: A liquid dispenser applicator for preoperative preparation of a target area of a patient's skin is comprised of two integrated components, a handle portion and a canister vessel. The two components are locked by a locking and sealing ring mechanism to prevent accidental rupture of the sterile antiseptic fluid in the canister vessel. When the lock is unlocked, the unit contains a perforator designed to initially slit the membrane followed by pushing it open further and thereafter venting it to provide dual-staged self-venting by the perforator for ease of flow.Type: ApplicationFiled: November 14, 2002Publication date: April 10, 2003Applicant: HealthpointInventors: Rex A. Hidle, Shawn B. Gentry, H. Paul Dorman
-
Patent number: 6540105Abstract: A liquid dispenser is provided for dispensing a desired amount of liquid from a bottle, without leakage or dripping. The bottle is mounted in a fixture attached to a wall. The bottle includes an inlet and an outlet, with one-way valves operatively sealed in the inlet and outlet ports. A foam-filled foot pump is operatively connected to the inlet valve for the inlet port, such that air may be pumped into the bottle to pressurize the contents thereof. Upon pressurization, the liquid is forced through the outlet valve in the outlet port. An air filter is provided for the pump, so as to preclude contamination of liquid in the bottle. Excess pressure is released through a relief valve to preclude over-dosing of liquid from the bottle.Type: GrantFiled: August 13, 2001Date of Patent: April 1, 2003Assignee: Healthpoint, Ltd.Inventors: H. Paul Dorman, John W. Feik, Shawn Gentry
-
Patent number: 6505985Abstract: A liquid dispenser applicator for preoperative preparation of a target area of a patient's skin is comprised of two integrated components, a handle portion and a canister vessel. The two components are locked by a locking and sealing ring mechanism to prevent accidental rupture of the sterile antiseptic fluid in the canister vessel. When the lock is unlocked, the unit contains a perforator designed to initially slit the membrane followed by pushing it open further and thereafter venting it to provide dual-staged self-venting by the perforator for ease of flow.Type: GrantFiled: August 21, 2001Date of Patent: January 14, 2003Assignee: Healthpoint, Ltd.Inventors: Rex A. Hidle, Shawn B. Gentry, H. Paul Dorman
-
Patent number: 6479060Abstract: A topical ointment pharmaceutical composition that uses a lipophilic base, a pharmaceutical active and, dispersed in the base, from about 1% to about 50% by weight of the total composition of hydrogenated non-melted castor oil in powder form. The result of using hydrogenated non-melted castor oil in powder form is a surprising pharmaceutical elegance perceived to be smoother in texture and more spreadable than an ointment made by melting the hydrogenated castor oil.Type: GrantFiled: September 4, 2001Date of Patent: November 12, 2002Assignee: Healthpoint, Ltd.Inventors: David P. Jones, David W. Hobson, Pilar P. Duque